BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 8650933)

  • 1. [Secondary disorders of lipid metabolism, metabolic syndrome and familial combined hyperlipidemia].
    Steinmetz A; Schäfer JR
    Wien Med Wochenschr; 1994; 144(12-13):299-307. PubMed ID: 8650933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence that non-lipid cardiovascular risk factors are associated with high prevalence of coronary artery disease in patients with heterozygous familial hypercholesterolemia or familial combined hyperlipidemia.
    Skoumas I; Masoura C; Pitsavos C; Tousoulis D; Papadimitriou L; Aznaouridis K; Chrysohoou C; Giotsas N; Toutouza M; Tentolouris C; Antoniades C; Stefanadis C
    Int J Cardiol; 2007 Oct; 121(2):178-83. PubMed ID: 17188767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical and biochemical features of atherosclerosis main risk factors in children of probands with primary hyperlipidemia].
    Alidzhanova KhG; Tvorogova MG; Rozhkova TA; Balakhonova TV; Vorob'eva LP; Masenko VP; Kukharchuk VV
    Ter Arkh; 1998; 70(1):19-23. PubMed ID: 9532645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic syndrome prevalence and characteristics in Greek adults with familial combined hyperlipidemia.
    Skoumas J; Papadimitriou L; Pitsavos C; Masoura C; Giotsas N; Chrysohoou C; Toutouza M; Panagiotakos D; Stefanadis C
    Metabolism; 2007 Jan; 56(1):135-41. PubMed ID: 17161236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum ferritin is a major determinant of lipid phenotype in familial combined hyperlipidemia and familial hypertriglyceridemia.
    Mateo-Gallego R; Calmarza P; Jarauta E; Burillo E; Cenarro A; Civeira F
    Metabolism; 2010 Feb; 59(2):154-8. PubMed ID: 19913843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperlipidemia, pregnancy and pancreatitis.
    De Chalain TM; Michell WL; Berger GM
    Surg Gynecol Obstet; 1988 Dec; 167(6):469-73. PubMed ID: 3187871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abdominal obesity and dyslipidemia in the metabolic syndrome: importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk.
    Carr MC; Brunzell JD
    J Clin Endocrinol Metab; 2004 Jun; 89(6):2601-7. PubMed ID: 15181030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hypertriglyceridemias].
    Delgado M; Torres MA; Bellod P; Rubio MJ; Azpeitia JG; Nuño J; de Oya M
    Rev Clin Esp; 1985 Oct; 177(5):203-8. PubMed ID: 3909257
    [No Abstract]   [Full Text] [Related]  

  • 10. Familial combined hyperlipidemia: upstream transcription factor 1 and beyond.
    Lee JC; Lusis AJ; Pajukanta P
    Curr Opin Lipidol; 2006 Apr; 17(2):101-9. PubMed ID: 16531745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary artery disease risk in familial combined hyperlipidemia and familial hypertriglyceridemia: a case-control comparison from the National Heart, Lung, and Blood Institute Family Heart Study.
    Hopkins PN; Heiss G; Ellison RC; Province MA; Pankow JS; Eckfeldt JH; Hunt SC
    Circulation; 2003 Aug; 108(5):519-23. PubMed ID: 12847072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prevalence of multiple coronary risk factors in Punjabi Bhatia community: Jaipur Heart Watch-3.
    Gupta R; Sarna M; Thanvi J; Rastogi P; Kaul V; Gupta VP
    Indian Heart J; 2004; 56(6):646-52. PubMed ID: 15751521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between familial combined hyperlipidemia and insulin resistance.
    Jackuliaková D; Vaverková H; Karásek D
    Vnitr Lek; 2008 Nov; 54(11):1045-53. PubMed ID: 19069677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial combined hyperlipidemia: controversial aspects of its diagnosis and pathogenesis.
    Aguilar Salinas CA; Zamora M; Gómez-Díaz RA; Mehta R; Gómez Pérez FJ; Rull JA
    Semin Vasc Med; 2004 May; 4(2):203-9. PubMed ID: 15478042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of obesity in primary hyperlipidemias.
    Carmena R; Ascaso JF; Real JT
    Nutr Metab Cardiovasc Dis; 2001 Oct; 11(5):354-9. PubMed ID: 11887432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hyperlipidemia, blood coagulation factors, hereditary familial factors and coronary atherosclerosis].
    Penco M; Del Porto G; Dagianti A
    Cardiologia; 1991 Dec; 36(12 Suppl 1):15-23. PubMed ID: 1841765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma triglycerides and type III hyperlipidemia are independently associated with premature familial coronary artery disease.
    Hopkins PN; Wu LL; Hunt SC; Brinton EA
    J Am Coll Cardiol; 2005 Apr; 45(7):1003-12. PubMed ID: 15808755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel drugs in familial combined hyperlipidemia: lessons from type 2 diabetes mellitus.
    Brouwers MC; de Graaf J; van Greevenbroek MM; Schaper N; Stehouwer CD; Stalenhoef AF
    Curr Opin Lipidol; 2010 Dec; 21(6):530-8. PubMed ID: 20739883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis.
    Sommer DM; Jenisch S; Suchan M; Christophers E; Weichenthal M
    Arch Dermatol Res; 2006 Dec; 298(7):321-8. PubMed ID: 17021763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Disorder of lipid metabolism in visceral fat syndrome--relation to familial combined hyperlipidemia].
    Ishigami M; Nakamura T; Matsuzawa Y
    Nihon Rinsho; 2002 May; 60(5):868-74. PubMed ID: 12029987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.